Niacin first (DrugBank: Niacin)
4 diseases告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
6 | パーキンソン病 | 0 |
78 | 下垂体前葉機能低下症 | 1 |
79 | 家族性高コレステロール血症(ホモ接合体) | 0 |
265 | 脂肪萎縮症 | 0 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT01237041 (ClinicalTrials.gov) | July 1, 2011 | 6/11/2010 | Free Fatty Acids, Body Weight, and Growth Hormones Secretion in Children | Free Fatty Acids, Body Weight, and Growth Hormone Secretion in Children | Obesity;Short Stature;Growth Hormone Deficiency | Drug: Niacin First;Drug: Placebo First;Drug: Dose-Establishing Study 1 Niacin 250mg;Drug: Dose-Establishing Study 1 Niacin 500mg;Drug: Dose-Establishing Study 2 Niacin 500mg | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | NULL | Terminated | 7 Years | 14 Years | All | 37 | Phase 1;Phase 2 | United States |